NOVN

PQNT · Weight increase · 3d

The weight of NOVARTIS AG-REG (NOVN) in Pictet Asset Management’s PQNT ETF increased from 1.3400% on 2026-07-17 to 1.3900% on 2026-07-19, marking three consecutive days of upward adjustment after a previous dip. This sequential accumulation for a Health Care sector constituent indicates that PQNT's AI signals, combined with its factor exposures across fundamentals, momentum, valuation, and sentiment, identified positive conditions within its ex-US developed-market universe. The fund's methodology, integrating AI with these traditional factors, suggests the system detected a reinforcing positive trend for NOVN during this specific period, likely correlating with a favorable price action. Given PQNT's periodic rebalancing schedule, these consistent adjustments imply a sustained signal strength across its complex AI overlay for NOVN. This precise maneuver by the relatively newer PQNT fund, launched in 2025, reflects its nuanced approach to investing in international developed-market stocks like NOVN based on evolving signal environments.

weight 1.320% → 1.390% (+0.070 pp)

Jul 19·now $146.28

PQNT · Weight increase · 2d

Pictet Asset Management's PQNT, an AI-managed ETF comprising approximately 300 international developed-market stocks, made specific adjustments to its NOVN holding. The fund's consecutive weight increases for NOVARTIS AG-REG on July 17th and 18th stem from the AI overlay’s analysis of multiple factor exposures, including fundamentals, momentum, valuation, and sentiment within the Health Care sector. As PQNT rebalances periodically rather than daily, this accumulation in a Swiss pharmaceutical company indicates a sustained positive signal identified by the AI’s methodology. This specific move by the newer 2025-launched fund suggests the AI found NOVN’s profile increasingly attractive among its ex-US developed-market universe at these recent levels.

weight 1.320% → 1.350% (+0.030 pp)

Jul 18·now $146.28

PQNT · Weight increase · 2d

Following a period where NOVN shares showed signs of consolidating and then initiated an upward trajectory, Pictet Asset Management's PQNT likely registered a confluence of positive signals. The fund's AI overlay, which integrates momentum, sentiment, and fundamental factor exposures across developed-international stocks, presumably identified this shift in the Health Care sector stalwart. This prompted the ETF's periodic rebalancing mechanism to increase NOVN's allocation, moving from 1.28% to 1.30% on June 24th and then to 1.35% on June 25th. Such an adjustment reflects PQNT's methodology of dynamically sizing positions based on AI-derived insights and evolving factor scores within its diverse ex-US portfolio.

weight 1.280% → 1.350% (+0.070 pp)

Jun 25·now $146.28

PQNT · Weight increase · 2d

The PQNT fund, managed by Pictet Asset Management, incrementally increased its allocation to NOVN (NOVARTIS AG-REG /CHF/) within the Health Care sector, moving from 1.2500% on May 14, 2026, to 1.3100% by May 21, 2026. This gradual adjustment in the AI-managed broad ex-US developed-market portfolio suggests a reinforcing positive signal for the Swiss pharmaceutical company. The detected consecutive weight increase indicates that PQNT's AI signals, combined with its underlying factor exposures—potentially driven by improving fundamentals, valuation, or momentum metrics—identified a strengthening investment case. Over this specific period, the sustained positive input from the AI overlay on NOVN likely aligned with observable market behavior or data points that triggered the periodic rebalancing mechanism of this newer fund, launched in 2025. This activity reflects how the fund's methodology integrates AI insights with traditional factor analysis to identify and respond to evolving opportunities within its international developed-market universe.

weight 1.290% → 1.310% (+0.020 pp)

May 21·now $146.28

PQNT · Weight increase · 2d

The PQNT ETF increased its weight in NOVARTIS AG-REG /CHF/ (NOVN) from 1.2500% to 1.2900% between May 15 and May 17, 2026, indicating a strengthened conviction in this Health Care sector constituent within its approximately 300 international developed-market stocks. This movement reflects Pictet Asset Management's AI signals, likely identifying positive developments in NOVN's fundamentals, momentum, or sentiment given its ex-US developed-market broad-style mandate. The consecutive daily adjustments, specifically the jump from 1.2500% to 1.2800% then 1.2900% on May 16-17, suggest a positive shift in NOVN’s factor exposures that reached a threshold for rebalancing, potentially coinciding with a favorable price action or new data indicating upward momentum or value. Such a sustained increase, despite the ETF's periodic rather than daily rebalancing nature, points to the AI overlay identifying consistent or accelerating positive signals for this specific Swiss pharmaceutical company.

weight 1.250% → 1.290% (+0.040 pp)

May 17·now $146.28

PQNT · Weight increase · 2d

The AI ETF likely increased NOVN's weight consecutively after detecting sustained positive signals, potentially from strong drug pipeline developments, robust earnings forecasts, or favorable sector trends within healthcare. This algorithmic conviction suggests the AI identifies a developing upside for Novartis, indicating more than a fleeting positive event. For retail investors, this pattern serves as a signal to conduct their own deeper due diligence into NOVN's recent performance and market catalysts, rather than simply following the AI blindly.

weight 1.100% → 1.260% (+0.160 pp)

Apr 30·entry $143.51·now $146.28Fresh